Abstract
Effects of three drugs, Gemfibrozil, Diltiazem and lsosorbide dinitrate (ISDN) on various lipid parameters were studied in patients with ischemic heart disease (IHD) with positive treadmill stress response. Gemfibrozil and diltiazem significantly lowered the levels of serum total lipids (TL), triglycerides (TG), phospholipids (PL), total cholesterol (TC), low density lipoprotein cholesterol (LDL-C) and very low density lipoprotein cholesterol (VLDL-C), and incroased the levels of serum high density lipoprotein cholesterol (HDL-C) significantly. However, patients administered with ISDN showed a significant increase in all the lipid parameters except HDL-C, which showed a significant decrease.
Similar content being viewed by others
References
Taylor, S.H. (1992) Therapeutic targets in ischaemic heart disease. Drugs. 43 (Suppl.1), 1–8.
Lipid Research Clinics Program (1984) The lipid research clinics primary prevention trial results I and II. J. Am. Med. Assoc. 251, 351–374.
Otterstand, J.E., Foreland, G., Wasenius Soeyland, A.K. and Illingworth, J.M. (1992) Lipid profile in 100 men with moderate hypertension treated for 1 year with atenolol or hydrochlorothiazide plus amiloride: a double-blind, randomized study. Scand. J. Clin. Lab. Invest. 52, 83–93.
Varley, H., Gowenlock, A.H. and Bell, M. (1980) Practical clinical Biochemistry, 5th edn. William Heinemann Medical Books Ltd., London, p 625–684.
Roberts, W.C. (1988) The Friedewald-Levy-Fredrickson formula for calculating low-density lipoprotein cholesterol, the basis for lipid-lowering therapy. Am. J. Cardiol. 62, 345–346.
Krause, R.M. (1982) Regulation of high density lipoprotein levels. Med. Clin. North. Am. 66, 403–430.
Fenderson, R.W., Deutsch, S., Manachemi, E., Chin, B. and Samuel, P. (1982) Effect of gemfibrozil on serum lipids in man, Angiology. 33, 581–593.
Nikkila, E.A., Ylikahri, R. and Huttunen, J.K. (1976) Effect on serum lipids, lipoproteins, post heparin plasma lipase activities and glucose tolerance in primary hypertriglyceridemia. Proc. R. Soc. Med. 69 (Suppl. 2), 58–63.
Vessby, B., Costner, G., Lithell, H. and Thomis, J. (1982) divergin effects of cholestyramine on apoprotein B and lipoprotein LP(a). Atherosclerosis. 44, 61–71.
Kesaniemi, Y.A. and Grundy, S.M. (1984) Influence of gemfibrozil and clofibrate on metabolism of cholesterol and plasma triglyceride in man. J. Am. Med. Assoc. 251, 2241–2246.
Saku, K., Gartiside, P.S., Hynd, B.A. and Kashyap, M.L. (1985) Mechanism of action of gemfibrozil on lipid metabolism. J. Clin. Invest. 75, 1702–1721.
Pool, E.P., Seagrren, S.C. and Salel, A.F. (1985) Effects of diltiazem on serum lipids, exercise performance and blood-pressure: Randomized, double-blind placebo controlled evaluation for systemic hypertension. Am. J. Cardiol. 56, 86H-91H.
Bernini, F., Catapano, A.L., Corsini, A., Fumagalli, R. and Paoletti, R. (1989) Effects of calcium antagonists on lipids and atherosclerosis. Am. J. Cardiol. 64, 129l-134l.
Loaldi, A., Polese, A., Montorsi, P., De Cesare, N, Fabbiocchi, F., Ravagnani, P. and Guazzi, M.D. (1989) Comparison of nifedipine, propranolol and isosorbide dinitrate on antiographic progression and regression of coronary arterial narrowings in angina pectoris. Am. J. Cardiol. 64, 433–439.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sharma, H.O., Sharma, S.K. A comparative study on the effects of Gemfibrozil, Diltiazem and Isosorbide dinitrate on lipid profile in patients of ischemic heart disease in India. Indian J Clin Biochem 12, 45–48 (1997). https://doi.org/10.1007/BF02867954
Issue Date:
DOI: https://doi.org/10.1007/BF02867954